Michael R Debaun MD MPH
Pediatric Anemia and Red Blood Cell Hematology
Professor, Pediatrics, Vanderbilt University School of Medicine
Join to View Full Profile
3601 21st Ave SNashville, TN 37232
Phone+1 615-322-3000
Fax+1 615-936-0605
Dr. Debaun is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michael Debaun is a pediatric hematologist/oncologist in Nashville, TN and is affiliated with multiple hospitals in the area, including Monroe Carell Jr. Childrens Hospital and Vanderbilt University Medical Center. He received his medical degree from Stanford University School of Medicine and has been in practice 30 years. He specializes in pediatric anemia and red blood cell hematology.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Pediatric Hematology/Oncology, 1990 - 1993- Washington University/B-JH/SLCH ConsortiumResidency, Pediatrics, 1987 - 1990
Stanford University School of MedicineClass of 1987
Certifications & Licensure
TN State Medical License 2011 - 2028
OK State Medical License 2025 - 2026
FL State Medical License 2013 - 2020
MD State Medical License 1992 - 2010
American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 2009
Clinical Trials
- Silent Cerebral Infarct Transfusion Multi-Center Clinical Trial Start of enrollment: 2004 Dec 01
- Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease Start of enrollment: 2012 Aug 16
- Sickle Cell Disease - Stroke Prevention in Nigeria Trial Start of enrollment: 2013 Apr 24
Publications & Presentations
PubMed
- Excellent outcomes using a novel reduced intensity conditioning with thiotepa and post-transplant cyclophosphamide for HLA-matched related donor transplant in adolesce...Reem Alasbali, Mohsen Alzahrani, Karina Wilkerson, Phavina Akhom, Fahad Alotaibi
Bone Marrow Transplantation. 2026-07-01 - Implementation of a Prospective Birth Cohort for Newborn Screening and Early Linkage to Comprehensive Sickle Cell Disease Care in a Low-Resource Setting.Umma A Ibrahim, Aisha B Musa, Oiza O Aliu-Isah, Hauwa A Inuwa, Zubaida L Farouk
International Journal of Neonatal Screening. 2026-06-16 - Cure Sickle Cell Initiative recommendations on common data elements for sickle cell disease gene therapy trials.Sophie Lanzkron, Victoria H Coleman-Cowger, Alexis A Thompson, C Patrick Carroll, Traci Clemons
Blood Advances. 2026-06-09
Journal Articles
- Silent Infarcts in Sickle Cell Anemia Occur in the Borderzone Region and Are Associated with Low Cerebral Blood FlowLori C Jordan, Andria L Ford, Melanie E Fields, Robert C McKinstry, Michael R DeBaun, Blood
- Pregnancy Outcomes in Women with Sickle‐Cell Disease in Low and High Income Countries: A Systematic Review and Meta‐AnalysisMichael R DeBaun, M H Aliyu, M G Tuuli, BJOG: An International Journal of Obstetrics & Gynaecology
Abstracts/Posters
- Cross Sectional Survey of Priapism and Sexual Dysfunction in 353 Men with Sickle Cell DiseaseMichael R. DeBaun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Decline in Forced Expiratory Volume in 1 Second in Older Adults with Sickle Cell Disease Is Similar to Adults with Cystic FibrosisMichael R. DeBaun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Reduced Intensity Conditioning for Haploidentical Bone Marrow Transplantation in Patients with Symptomatic Sickle Cell Disease: BMT CTN Protocol 1507Michael R. DeBaun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Pediatric Clinical Non-Malignant Hematology61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Pediatric Clinical Non-Malignant Hematology61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- ASH Clinical Practice Guidelines on Sickle Cell Disease60th American Society of Hematology Annual Meeting - 12/2/2018
Other
- Overview of the management of sickle cell diseaseDeBaun MR, Vichinsky EP, Field JJ
http://www.uptodate.com/contents/overview-of-the-management-of-sickle-cell-disease
UpToDate, Wolters Kluwer Health - 2013-02-21 - Diagnosis and management of priapism in sickle cell diseaseDeBaun MR, Field JJ, Vemulakonda VM
http://www.uptodate.com/contents/diagnosis-and-management-of-priapism-in-sickle-cell-disease
UpToDate, Wolters Kluwer Health - 2012-04-10 - Hepatic manifestations of sickle cell diseaseDeBaun MR, Banerjee S
http://www.uptodate.com/contents/hepatic-manifestations-of-sickle-cell-disease
UpToDate, Wolters Kluwer Health - 2012-04-24
Press Mentions
Vanderbilt-Ingram Researchers Present Cancer Advancements at ASH 2025December 4th, 2025
Meharry Student Earns 2025 American Society of Hematology HIP AwardJune 6th, 2025
Fewer Side Effects with New Sickle Cell TreatmentApril 23rd, 2025
Grant Support
- Stroke Prevention in Nigeria: SPRING 2VANDERBILT UNIVERSITY MEDICAL CENTER2023–2029
- Stroke Prevention in Nigeria: SPRING 2VANDERBILT UNIVERSITY MEDICAL CENTER2023–2029
- Pathogenesis, Targeted Therapeutics, and New Vaccines for Childhood DiseaseVANDERBILT UNIVERSITY MEDICAL CENTER2026–2027
- Clonal hematopoiesis and inherited genetic variation in sickle cell diseaseVANDERBILT UNIVERSITY MEDICAL CENTER2023–2027
- Vanderbilt Stimulating Access to Research in Residency (V-StARR)VANDERBILT UNIVERSITY MEDICAL CENTER2023–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
